Non-Hodgkin's LymphomaReferencesCitationsFisher RI, et al. (2005). Non-Hodgkin's lymphomas. In
VT DeVita Jr et al., eds., Cancer: Principles and Practice of
Oncology, 7th ed., pp. 1957–1997. Philadelphia: Lippincott Williams and
Williams. American Cancer Society (2005). Cancer
Facts and Figures 2005, pp. 1–21. Atlanta: American Cancer Society. Also
available online:
http://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf. Evans LS, Hancock BW (2003). Non-Hodgkin lymphoma.
Lancet, 362(9378): 139–146. Ardeshna KM, et al. (2003). Long-term effect of a
watch and wait policy versus immediate systemic treatment for asymptomatic
advanced-stage non-Hodgkin lymphoma: A randomised controlled trial.
Lancet, 362(9383): 516–522. Coiffier B, et al. (2002). CHOP chemotherapy plus
rituximab compared with CHOP alone in elderly patients with diffuse
large-B-cell lymphoma. New England Journal of Medicine,
346(4): 235–242. Milpied N, et al. (2004). Initial treatment of
aggressive lymphoma with high-dose chemotherapy and autologous stem-cell
support. New England Journal of Medicine, 350(13):
1287–1295.
Other Works ConsultedAmerican Joint Committee on Cancer (2002). Lymphoid
neoplasms. AJCC Cancer Staging Manual, 6th ed., pp.
393–406. New York: Springer-Verlag. Foon KA, Fisher RI (2006). The non-Hodgkin lymphomas.
In MA Lichtman et al., eds., Williams Hematology, 7th
ed., pp. 1407–1459. New York: McGraw-Hill. McCune SL, et al. (2001). Monoclonal antibody therapy
in the treatment of non-Hodgkin lymphoma. JAMA, 286(10):
1149–1152.
| |